Alterations in dopamine receptors: effect of lesion and haloperidol treatment.
D000818:Animals; D001058:Apomorphine / Q000378:metabolism; D003342:Corpus Striatum / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology*; D006892:Hydroxydopamines / Q000494:pharmacology*; D008032:Limbic System / Q000502:physiology; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013134:Spiperone / Q000494:pharmacology; D013378:Substantia Nigra / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D013134:Spiperone; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D001058:Apomorphine